Treatment Outcomes in a Decentralized Antiretroviral Therapy Program : A Comparison of Two Levels of Care in North Central Nigeria

Abstract EN

Background.

Decentralization of antiretroviral therapy (ART) services is a key strategy to achieving universal access to treatment for people living with HIV/AIDS.

Our objective was to assess clinical and laboratory outcomes within a decentralized program in Nigeria.

Methods.

Using a tiered hub-and-spoke model to decentralize services, a tertiary hospital scaled down services to 13 secondary-level hospitals using national and program guidelines.

We obtained sociodemographic, clinical, and immunovirologic data on previously antiretroviral drug naïve patients aged ≥15 years that received HAART for at least 6 months and compared treatment outcomes between the prime and satellite sites.

Results.

Out of 7,747 patients, 3729 (48.1%) were enrolled at the satellites while on HAART, prime site patients achieved better immune reconstitution based on CD4+ cell counts at 12 (P<0.001) and 24 weeks (P<0.001) with similar responses at 48 weeks (P=0.11) and higher rates of viral suppression (<400 c/mL) at 12 (P<0.001) and 48 weeks (P=0.03), but similar responses at 24 weeks (P=0.21).

Mortality was 2.3% versus 5.0% (P<0.001) at prime and satellite sites, while transfer rate was 8.7% versus 5.5% (P=0.001) at prime and satellites.

Conclusion.

ART decentralization is feasible in resource-limited settings, but efforts have to be intensified to maintain good quality of care.